Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE , more than five years after both ...

Background Immunogenicity to SARS-CoV-2 vaccination in patients with SLE varies by vaccine type and immune-modulating therapy. However, data in Southeast Asian populations, especially among Thai ...

India's Coronavirus Vaccine Market offers growth through government-led initiatives, robust manufacturing, and R&D in vaccine ...

For children, the safer path during the pandemic wasn’t a roll of the dice with infection - it was vaccination.

Wall Street analysts also expect sales of the COVID-19 vaccine Spikevax from Moderna to tumble about 50% in the third quarter ...

The health impact of a Covid infection was higher than the risks from the vaccine for teens and children - but it won't ...

Getting covid-19 for the first time slightly increased the risk of heart inflammation, blood clots and bleeding disorders among children, whereas being vaccinated against the virus was much safer and ...

Experts have long sounded the alarm over myocarditis, an extremely rare complication of the vaccine that causes inflammation ...

(RTTNews) - While reporting financial results for the third quarter on Monday, immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) said it now expects revenues for the ...

Conference call and webcast scheduled for November 3, 2025, at 8:00 a.m. EST (2:00 p.m. CET) MAINZ, Germany, November 3, 2025 (GLOBE NEWSWIRE)-- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) ...

Pfizer Inc ((PFE)), Biontech Se Sponsored Adr ((BNTX)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced ...

MAINZ, Germany, October 27, 2025 (GLOBE NEWSWIRE)-- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the third quarter 2025 on Monday, November 3, 2025.